Please login to the form below

Not currently logged in

Eisai's cancer cookbook wins CSR award

Around the Kitchen Table project see success at PMEA 2014
PMEA 2014 Eisai CSR

A cookbook Eisai developed to support people on chemotherapy was rewarded at last night's PMEA 2014 as a standout example of what pharma can do when it comes to corporate social responsibility.

Eisai developed the cookbook Around the Kitchen Table in partnership with the cancer support network Maggie's, chef and cookery author Penny Ericson, an NHS dietitian and cancer patients. The company also enlisted the services of comms agency Tonic Life Communications.

The cookbook, which picked up the ABPI Award for Excellence in Corporate Social Responsibility, contains more than 50 recipes and dietary information for people with cancer who are undergoing chemotherapy. It has been distributed to Maggie's centres, other cancer charities, Eisai employees and healthcare professionals. An e-book is also available to download for free.

PMEA judges said Eisai created a “truly outstanding CSR campaign that far exceeded all initial expectations and delivered great patient-centric outcomes”.

They added: “With this clear and different approach they went on to develop a programme that had a positive impact on a topic that is rarely considered by pharmaceutical companies but has a massive impact for patients.”

The Around the Kitchen Table project was also a finalist in the category Excellence in Patient Focus.

Run by PMLiVE's publisher the PMGroup, the PMEA programme is specifically designed to recognise and commend excellence, best practice and innovation in local, European and international healthcare markets.

Article by
Thomas Meek

13th November 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge